[Federal Register Volume 88, Number 67 (Friday, April 7, 2023)]
[Notices]
[Pages 20895-20896]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-07274]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Neurological Disorders and Stroke Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. The open session of the meeting
will also be videocast. Individuals who plan to attend or participate
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections
[[Page 20896]]
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant
applications and the discussions could disclose confidential trade
secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Advisory Neurological Disorders and
Stroke Council.
Date: May 31-June 1, 2023.
Open: May 31, 2023, 1:00 p.m. to 5:30 p.m.
Agenda: Report by the Director, NINDS; Report by the Director,
Division of Extramural Activities; and Administrative and Program
Developments.
Open session will be videocast from this link: https://videocast.nih.gov/.
Closed: June 1, 2023, 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, Room 160,
6701 Rockledge Drive, Bethesda, Maryland 20817.
Contact Person: Robert Finkelstein, Ph.D., Director of
Extramural Research, National Institute of Neurological, Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite 3309, MSC 9531,
Bethesda, MD 20892, (301) 496-9248, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice at least 10 days in advance of the meeting. The
statement should include the name, address, telephone number and
when applicable, the business or professional affiliation of the
interested person.
Information is also available on the Institute's/Center's home
page: www.ninds.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a
meeting on campus or at an off-campus federal facility will be asked
to show one form of identification (for example, a government-issued
photo ID, driver's license, or passport) and to state the purpose of
their visit.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: April 3, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-07274 Filed 4-6-23; 8:45 am]
BILLING CODE 4140-01-P